#NEJM

Dr. Purvi Parwani

purviparwani

Doing this as PSA!Those who are worried about side effects of the vaccine- here is the @NEJM paper on #Pfizer #Covid vaccine! https://www.nejm.org/doi/10.1056/NEJMoa2034577@DBelardoMD @mirvatalasnag @onco_cardiology @AChoiHeart @SaynaNorouz

David Paton

cricketwyvern

The big news about this NEJM piece is that it’s not really news, being consistent with what we already knew:when schools are open teachers do not seem to face higher

Justin Mott

DrJustinMott

Leadership has defined this past year, for me. Taught a leadership course, directed our MD-PhD program @UNMC_mdphd, and used all of my coping skills to withstand a national leadership vacuum.

Andrew💙Croxford

andrew_croxford

One aspect of testing that I’m interested in (but absolutely no expert) is the correlation between +ve qPCR, and subsequent viral culture. The idea being that if you test +ve

Céline Gounder, MD, ScM, FIDSA

celinegounder

1/ Should we give as many people one dose of the Pfizer and Moderna vaccines as possible? Or half as many people two doses of vaccine? It’s a data-free zone.https://twitter.com/CitizenCohn/status/1358075667573862401

Priya Sampathkumar

PSampathkumarMD

Pfizer-BioNTech COVID-19 VACCINE UPDATEThread Pfizer-BioNTech and Moderna, have applied for @US_FDA Emergency Use Authorization for their mRNA based vaccines. Here is what we know about the Pfizer vaccine and what

Adia Benton

Ethnography911

Today the NYT published something about the pulse oximeter letter that came out in the NEJM last week. There are many things that piss me off about it -- knowing

John Lam - It's OK!

john_lam

THREAD 1. Today's announcement of the 90% efficacy of the Pfizer vaccine, BNT162b2, from preliminary analysis of their Phase 3 study was more great news today. So I'm writing this

Eric Feigl-Ding

DrEricDing

NEW—official full trial results of Pfizer/BioNTech vaccine in 43,448 people:95% efficacy w/ 2 doses52% efficacy after 1st dose (before 2nd)10 severe cases, 9 were in placeboSerious adverse events low &

Andrew💙Croxford

andrew_croxford

SMALL THREAD: With the news now of the Pfizer/BioNTech approval in the UK, here a paper summarising an early dose-escalation trial assessing safety, but also immunogenicity (ability to induce an

megan culler freeman md, phd

mcfreeID

You may have heard my conversation with @jasonbnpr on @NPR this weekend as to why kids make up a relatively low percentage of #COVID cases overall,

Josh Barocas, MD

jabarocas

Really important work going on for the emerging epidemic within the pandemic: methamphetamine use disorder. Brief Study for some efficacy of bupropion + naltrexone (13.6%) v placebo (2.5%). @NEJM. (Brief

James Todaro, MD

JamesTodaroMD

1/ Vaccine mandates are quickly moving from "conspiracy theory" to reality.In a recent interview, Dr. Fauci asserted that the only return to "normal" is vaccination in 75-80% of the US.Let's

Eric Feigl-Ding

DrEricDing

DEBUNKING HYDROXYCHLOROQUINE (again)—w/ that viral HCQ video today, it’s time to bump up this thread on the mega RECOVERY randomized trial of HCQ with 4700 people showing NO benefit

HermisHuman

Andy_Redd

The South African serology results from the @Novavax vaccine trial drastically need more clarification. From the protocol posted in their Phase 2 results it appears they used an in-house ELISA

arkancide_is_real

Arkancideisreal

@richardursomd not had time to look through this thoroughly but it doesn't pass the sniff test.(SHORT THREAD)Immediately publication in the corrupted @NEJM raises red flags.A previously hardly published (first) author

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.